2seventy bio (NASDAQ:TSVT) reported its Q3 earnings results on Tuesday, November 14, 2023 at 07:00 AM.
Here’s what investors need to know about the announcement.
Earnings
2seventy bio missed estimated earnings by 3.09%, reporting an EPS of $-1.0 versus an estimate of $-0.97.
Revenue was down $1.37 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.32 which was followed by a 4.98% increase in the share price the next day.
Here’s a look at 2seventy bio’s past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -1.15 | -1.22 | -1.61 | -1.80 |
| EPS Actual | -0.83 | -1.08 | -0.60 | -1.76 |
| Revenue Estimate | 36.88M | 22.30M | 15.52M | 12.36M |
| Revenue Actual | 36.05M | 41.62M | 56.18M | 13.41M |
To track all earnings releases for 2seventy bio visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
